The event, called “Improving care for chronic patients in lower-income countries: the patient journey,” will take place November 29, 2016, on the Novartis Campus in Basel, Switzerland and will also be webcast.
Learn how Novartis is working with chronic obstructive pulmonary disease (COPD) patients to develop digital health technologies that help them find their “new normal.”
Dr. George Vratsanos, rheumatologist and Executive Global Program Head at Novartis Pharmaceuticals, shares his team’s top five principles that are at the heart of our clinical trial program.
